The spectrum of axonopathies: From CMT2 to HSP

Neurology

Volumn 83, Issue 7, 2014, Pages 580-581

  Fridman, Vera ^a   Murphy, Sinéad M ^b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b ADELAIDE AND MEATH HOSPITAL   (Ireland)

^c TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CEREBELLAR ATAXIA; COGNITIVE DEFECT; EDITORIAL; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MISSENSE MUTATION; NERVE FIBER TRANSPORT; NEUROPATHY; NEXT GENERATION SEQUENCING; PHENOTYPE; PRIORITY JOURNAL; PYRAMIDAL SIGN; SPASTIC PARAPLEGIA; FEMALE; GENETICS; MALE; MUTATION; NOTE;

KIF5A PROTEIN, HUMAN; KINESIN;

CHARCOT-MARIE-TOOTH DISEASE; FEMALE; HUMANS; KINESIN; MALE; MUTATION; SPASTIC PARAPLEGIA, HEREDITARY;

EID: 84907424670     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000700     Document Type: Editorial

References (5)

1. Timmerman V, Clowes VE, Reid E. Overlapping molecular pathological themes link Charcot-Marie-Tooth neuropathies and hereditary spastic paraplegias. Exp Neurol 2013; 246:14-25.
2. Goizet C, Boukhris A, Mundwiller E, et al. Complicated forms of autosomal dominant hereditary spastic paraplegia are frequent in SPG10. Hum Mutat 2009;30:E376-E385.
3. Crimella C, Baschirotto C, Arnoldi A, et al. Mutations in the motor and stalk domains of KIF5A in spastic paraplegia type 10 and in axonal Charcot-Marie-Tooth type 2. Clin Genet 2012;82:157-164.
4. Liu YT, Laurá M, Hersheson J, et al. Extended phenotypic spectrum of KIF5A mutations: from spastic paraplegia to axonal neuropathy. Neurology 2014;83:612-619.
5. Rossor AM, Polke JM, Houlden H, Reilly MM. Clinical implications of genetic advances in Charcot-Marie-Tooth disease. Nat Rev Neurol 2013;9:562-571.